WO2015194970A3 - Method of treating or preventing multiple sclerosis using one or more neural regeneration peptides - Google Patents

Method of treating or preventing multiple sclerosis using one or more neural regeneration peptides Download PDF

Info

Publication number
WO2015194970A3
WO2015194970A3 PCT/NZ2015/050075 NZ2015050075W WO2015194970A3 WO 2015194970 A3 WO2015194970 A3 WO 2015194970A3 NZ 2015050075 W NZ2015050075 W NZ 2015050075W WO 2015194970 A3 WO2015194970 A3 WO 2015194970A3
Authority
WO
WIPO (PCT)
Prior art keywords
treating
multiple sclerosis
preventing multiple
neural regeneration
regeneration peptides
Prior art date
Application number
PCT/NZ2015/050075
Other languages
French (fr)
Other versions
WO2015194970A2 (en
Inventor
Frank Sieg
Original Assignee
Curonz Holdings Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curonz Holdings Company Limited filed Critical Curonz Holdings Company Limited
Publication of WO2015194970A2 publication Critical patent/WO2015194970A2/en
Publication of WO2015194970A3 publication Critical patent/WO2015194970A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a method of treating or preventing multiple sclerosis in an animal subject using one or more neural regeneration peptides (NRPs). In particular, the invention relates to the use of NRP 2945 and closely related analogues for treating or preventing multiple sclerosis or seizures in an animal subject. More particularly, the invention relates to the use of NRP 2945 and closely related analogues to prevent the axonal damage or demyelination of central nervous system cells.
PCT/NZ2015/050075 2014-06-20 2015-06-19 Method of treating or preventing multiple sclerosis using one or more neural regeneration peptides WO2015194970A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ62651814 2014-06-20
NZ626518 2014-06-20

Publications (2)

Publication Number Publication Date
WO2015194970A2 WO2015194970A2 (en) 2015-12-23
WO2015194970A3 true WO2015194970A3 (en) 2016-07-28

Family

ID=54936209

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NZ2015/050075 WO2015194970A2 (en) 2014-06-20 2015-06-19 Method of treating or preventing multiple sclerosis using one or more neural regeneration peptides

Country Status (1)

Country Link
WO (1) WO2015194970A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2646817C1 (en) * 2016-12-27 2018-03-07 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) Peptide from the composition of the immunoglobulin human heavy chain, suitable for treatment of multiple sclerosis
CN108642129A (en) * 2018-05-03 2018-10-12 杭州端丽生物技术有限公司 The medical usage of impulsion control disorder biological detection marker and Impulsins
CN111304167B (en) * 2018-12-12 2024-03-26 上海泉眼生物科技有限公司 Neuron precursor cells derived from human adipose-derived stem cells, and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110098228A1 (en) * 2007-10-17 2011-04-28 Neuren Pharmaceuticals Limited Synthetic analogues of neural regeneration peptides
WO2014017927A1 (en) * 2012-07-27 2014-01-30 Curonz Holdings Company Limited Method of treating optic nerve damage, ophthalmic ischemia or ophthalmic reperfusion injury

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110098228A1 (en) * 2007-10-17 2011-04-28 Neuren Pharmaceuticals Limited Synthetic analogues of neural regeneration peptides
WO2014017927A1 (en) * 2012-07-27 2014-01-30 Curonz Holdings Company Limited Method of treating optic nerve damage, ophthalmic ischemia or ophthalmic reperfusion injury

Also Published As

Publication number Publication date
WO2015194970A2 (en) 2015-12-23

Similar Documents

Publication Publication Date Title
GB201720669D0 (en) The distributed data storage system and method based on block chain
ZA201902254B (en) A shunt system, shunt and method for treating an ocular disorder
EP3509876A4 (en) Tire management system and method
EP3180073A4 (en) Systems and methods for neurostimulation electrode configurations based on neural localization
EP3512415A4 (en) Systems and methods for modeling neural architecture
EP3308309A4 (en) Neural network architectures for linking biological sequence variants based on molecular phenotype, and systems and methods therefor
EP3289552A4 (en) Digitally encrypted securities platform, along with methods and systems for the same
EP3313168A4 (en) System and method for prescriptive seed treatment
EP3136252A4 (en) Euicc management method, euicc, sm platform and system
EP3551063A4 (en) System and method for high density electrode management
EP3495970A4 (en) Key-value storage method, apparatus and system
GB201715212D0 (en) System, method and apparatus for preserving vehicle battery
EP3509018A4 (en) Method for biologically storing and restoring data
EP3306477A4 (en) Storage device and block storage method based on the storage device
EP3305889B8 (en) Method for inducing differentiation of neural crest cells into neurons of the autonomic nervous system
EP3484349A4 (en) Neuromodulation apparatus, method and system
PL3051023T3 (en) Film containing cork particles , artificial leather containing cork particles and method for producing the same
EP3491224A4 (en) Methods and systems for removing deposits in an aftertreatment system
WO2016040824A3 (en) METHODS OF IDENTIFYING MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USE OF SAME TO MODULATE mTORC1
EP3497640A4 (en) Contract management system, apparatus, and method
EP3347844A4 (en) Method and system for diagnosing disease and generating treatment recommendations
EP3647145A4 (en) Artificial emotion generation method, travel evaluation method, and travel evaluation system
GB201504607D0 (en) Methods,tools and systems for the assessment,preventation,management and treatment selection for type 2 diabetes
WO2015194970A3 (en) Method of treating or preventing multiple sclerosis using one or more neural regeneration peptides
CA2986376C (en) Poxvirus-derived promoter, and vector comprising same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15809583

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15809583

Country of ref document: EP

Kind code of ref document: A2